NUZ 0.00% 23.0¢ neurizon therapeutics limited

Top 100 PAA Option Holders as at 29/12/2020 with only one variation.variations., page-7

  1. 1,409 Posts.
    lightbulb Created with Sketch. 993
    Hey Lastly, do we think that Epichem will still be self-supporting once the DNDi contract expires? They have stated that spare capacity is being largely taken up with work from PAA but this is not self-supporting income as PAA owns Epichem, so really they are just paying themselves.

    Also, without an update on how the OHD Shell project went we don't know the potential here either, it could be really huge! but there is the chance that it was a flop. I've been thinking about this a bit. Would Shell want to keep the results confidential (as it appears they have) if they were good and they have intentions to expand it? IMO this is more likely than if it had been a flop and they were not interested. So, maybe we will hear more good news in the coming months. The license for the OHD tech costs us a fair chunk of change each year as well, so we'll need to see some sort of a payback or it will further drain our coffers.
    Last edited by illdrink2that: 02/01/23
 
watchlist Created with Sketch. Add NUZ (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.